- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about REGN
Recent news which mentions REGN
From Benzinga
From Benzinga
From Benzinga
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
April 11, 2022
From Benzinga
Michael Grimm Purchases $5.66 Million Worth Of Energy Transfer & Other Notable Insider Buys
April 11, 2022
From Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
From Benzinga
This Exciting Biotech Stock Could Be Your Next 10-Bagger
April 10, 2022
From Motley Fool
This Is What Whales Are Betting On Regeneron Pharmaceuticals
April 08, 2022
Tickers
REGN
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
From Benzinga
From Benzinga
Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2 Inflammation
April 07, 2022
From Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
April 06, 2022
Tickers
REGN
From Benzinga
BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week in latest sign of how dominant it has become
April 06, 2022
From MarketWatch
7 Safe Stocks to Buy to Guard Against a Recession
April 05, 2022
From InvestorPlace
Annual Boosters Might Not Give Moderna the Boost It Needs
April 05, 2022
From InvestorPlace
Executives Sell More Than $262M Of 5 Stocks
April 04, 2022
From Benzinga
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
March 28, 2022
From Benzinga
Regeneron-Sanofi's Dupixent Significantly Improved Signs, Symptoms In Chronic Itchy Skin Disease
March 28, 2022
From Benzinga
3 Top Stock-Split Candidates After Amazon and Alphabet
March 25, 2022
From Motley Fool
Amazon Stock Split: 3 Companies That Should Follow Suit
March 24, 2022
From Motley Fool
From Benzinga
1 Great Income Stock to Buy and Hold Forever
March 16, 2022
From Motley Fool
From Benzinga
Is Regeneron Stock a Buy Now?
March 11, 2022
From Motley Fool
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.